[Skip to content]

Royal Brompton & Harefield NHS Foundation Trust
Our research
Search our Site
Bronchiectasis treatments

Our research

Active research studies

The Trust hosts a variety of research studies covering the breadth of its clinical practice. These are funded by a variety of sponsors including National Institute for Health Research (NIHR), UK research councils, European funding agencies, research charities and industry. 


Below is a list of approved projects that are currently recruiting volunteers.

  

Research studies

Specialty CategoryResearch titleStudy contact informationMore info
Chronic obstructive pulmonary diseaseCLEAN-PCD: A Phase 2a, Randomized, Double-blind, Placebo-controlled, IncompleteBlock Crossover Study to Evaluate the Safety and Efficacy of VX-371 Solution forInhalation in Subjects with Primary Ciliary DyskinesiaNajwa Soussi and Nia VoaseMore info
Chronic obstructive pulmonary diseaseRejuvenAir System Chronic Bronchitis Version 2Justin GarnerMore info
Chronic obstructive pulmonary diseaseINS-312: An Open-Label Safety Extension Study to a Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult Patients with Nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium avium complex (MAC) that are refractory to trNajwa SoussiMore info
Chronic obstructive pulmonary diseaseLung Function Improvement after Bronchoscopic Lung Volume Reduction with Pulmonx Endobronchial Valves used in Treatment of Emphysema (Liberate)Dr Justin GarnerMore info
Chronic obstructive pulmonary diseaseTargeted retreatment of COPD exacerbationsSimon BrillMore info
Chronic obstructive pulmonary diseaseAIRWAY EFFECTS OF TIOTROPIUM IN PATIENTS WITH COPDSally MeahMore info
Chronic obstructive pulmonary diseaseCOPD Exacerbations and Environmental Exposure ModellingLiz MooreMore info
Chronic obstructive pulmonary diseaseA Randomized, Open-Label, Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult Patients with Nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium avium complex (MAC) that are refractory to treatment - INS-212 (RESP 5Najwa SoussiMore info
Chronic obstructive pulmonary diseaseOPIPMike PolkeyMore info
Chronic obstructive pulmonary diseaseON-EPIC Nitrate supplementation to enhance rehabilitation in COPDMatthew PavittMore info

See details of the Trust’s performance for all clinical trials reported to the NIHR (PDF, 276KB), for the set-up and delivery of studies in the period 1 October 2016 to 30 September 2017.

Royal Brompton

Sydney Street,
London SW3 6NP
Tel: +44 (0)20 7352 8121

Harefield